Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 379

1.

An Elemental Impurities Excipient Database: A Viable Tool for ICH Q3D Drug Product Risk Assessment.

Boetzel R, Ceszlak A, Day C, Drumm P, Bejar JG, Glennon J, Harris L, Heghes CI, Horga R, Jacobs PL, Keurentjes WJTM, King F, Lee CW, Lewen N, Marchant CA, Maris FA, Nye W, Powell S, Rockstroh H, Rutter L, Schweitzer M, Shannon E, Smallshaw L, Teasdale A, Thompson S, Wilkinson D.

J Pharm Sci. 2018 Apr 18. pii: S0022-3549(18)30212-0. doi: 10.1016/j.xphs.2018.04.009. [Epub ahead of print]

PMID:
29679706
2.

The Inpatient Assessment and Management of Motor Functional Neurological Disorders: An Interdisciplinary Perspective.

McKee K, Glass S, Adams C, Stephen CD, King F, Parlman K, Perez DL, Kontos N.

Psychosomatics. 2018 Jan 8. pii: S0033-3182(17)30268-2. doi: 10.1016/j.psym.2017.12.006. [Epub ahead of print]

PMID:
29628294
3.

Motion compensation for MRI-compatible patient-mounted needle guide device: estimation of targeting accuracy in MRI-guided kidney cryoablations.

Tokuda J, Chauvin L, Ninni B, Kato T, King F, Tuncali K, Hata N.

Phys Med Biol. 2018 Apr 13;63(8):085010. doi: 10.1088/1361-6560/aab736.

PMID:
29546845
4.

Introduction of a dose-banding system for parenteral chemotherapy on a haematology-oncology day ward.

O'Leary CE, Collins A, Henman MC, King F.

J Oncol Pharm Pract. 2017 Jan 1:1078155217736376. doi: 10.1177/1078155217736376. [Epub ahead of print]

PMID:
29059028
5.

Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma.

Wood AC, Krytska K, Ryles HT, Infarinato NR, Sano R, Hansel TD, Hart LS, King FJ, Smith TR, Ainscow E, Grandinetti KB, Tuntland T, Kim S, Caponigro G, He YQ, Krupa S, Li N, Harris JL, Mossé YP.

Clin Cancer Res. 2017 Jun 1;23(11):2856-2868. doi: 10.1158/1078-0432.CCR-16-1114. Epub 2016 Dec 16.

PMID:
27986745
6.

Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.

Lawson R, Ryan J, King F, Goh JW, Tichy E, Marsh K.

Pharmacoeconomics. 2017 Feb;35(2):225-235. doi: 10.1007/s40273-016-0454-4.

PMID:
27663572
7.

Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery.

Wang Y, Cornett A, King FJ, Mao Y, Nigsch F, Paris CG, McAllister G, Jenkins JL.

Cell Chem Biol. 2016 Jul 21;23(7):862-874. doi: 10.1016/j.chembiol.2016.05.016. Epub 2016 Jul 14.

8.

Opioid-Induced Constipation among a Convenience Sample of Patients with Cancer Pain.

Coyne KS, Sexton C, LoCasale RJ, King FR, Margolis MK, Ahmedzai SH.

Front Oncol. 2016 Jun 8;6:131. doi: 10.3389/fonc.2016.00131. eCollection 2016.

9.

Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.

Lawson R, King F, Marsh K, Altincatal A, Cimen A.

Adv Ther. 2016 Aug;33(8):1331-46. doi: 10.1007/s12325-016-0365-y. Epub 2016 Jun 24.

10.
11.

The extraordinary joint material of an articulated coralline alga. I. Mechanical characterization of a key adaptation.

Denny MW, King FA.

J Exp Biol. 2016 Jun 15;219(Pt 12):1833-42. doi: 10.1242/jeb.138859.

12.

Delayed Posthypoxic Leukoencephalopathy: Improvement with Antioxidant Therapy.

King F, Morris NA, Schmahmann JD.

Case Rep Neurol. 2015 Dec 24;7(3):242-6. doi: 10.1159/000441892. eCollection 2015 Sep-Dec.

13.

Patient Test Preference for Colorectal Cancer Screening and Screening Uptake in an Insured Urban Minority Population.

Wolf RL, Basch CE, Zybert P, Basch CH, Ullman R, Shmukler C, King F, Neugut AI.

J Community Health. 2016 Jun;41(3):502-8. doi: 10.1007/s10900-015-0123-0.

PMID:
26585609
14.

Dark chemical matter as a promising starting point for drug lead discovery.

Wassermann AM, Lounkine E, Hoepfner D, Le Goff G, King FJ, Studer C, Peltier JM, Grippo ML, Prindle V, Tao J, Schuffenhauer A, Wallace IM, Chen S, Krastel P, Cobos-Correa A, Parker CN, Davies JW, Glick M.

Nat Chem Biol. 2015 Dec;11(12):958-66. doi: 10.1038/nchembio.1936. Epub 2015 Oct 19.

PMID:
26479441
15.

Thermal variation, thermal extremes and the physiological performance of individuals.

Dowd WW, King FA, Denny MW.

J Exp Biol. 2015 Jun;218(Pt 12):1956-67. doi: 10.1242/jeb.114926. Review.

16.

A Randomized Trial to Compare Alternative Educational Interventions to Increase Colorectal Cancer Screening in a Hard-to-Reach Urban Minority Population with Health Insurance.

Basch CE, Zybert P, Wolf RL, Basch CH, Ullman R, Shmukler C, King F, Neugut AI, Shea S.

J Community Health. 2015 Oct;40(5):975-83. doi: 10.1007/s10900-015-0021-5.

PMID:
25850386
17.

Opioid-Induced Constipation Among Patients with Chronic Noncancer Pain in the United States, Canada, Germany, and the United Kingdom: Laxative Use, Response, and Symptom Burden Over Time.

Coyne KS, Margolis MK, Yeomans K, King FR, Chavoshi S, Payne KA, LoCasale RJ.

Pain Med. 2015 Aug;16(8):1551-65. doi: 10.1111/pme.12724. Epub 2015 Mar 20.

PMID:
25802051
18.

The problem with BEAUTY: a medical librarian's perspective.

King F.

BMJ. 2015 Jan 20;350:h312. doi: 10.1136/bmj.h312. No abstract available.

PMID:
25647066
19.

Design and development of a mobile image overlay system for needle interventions.

Anand M, King F, Ungi T, Lasso A, Rudan J, Jayender J, Fritz J, Carrino JA, Jolesz FA, Fichtinger G.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:6159-62. doi: 10.1109/EMBC.2014.6945035.

20.

The Charlson comorbidity index can be used prospectively to identify patients who will incur high future costs.

Charlson M, Wells MT, Ullman R, King F, Shmukler C.

PLoS One. 2014 Dec 3;9(12):e112479. doi: 10.1371/journal.pone.0112479. eCollection 2014.

21.

Meta-analysis of the effects of lifestyle modifications on coronary and carotid atherosclerotic burden.

Jhamnani S, Patel D, Heimlich L, King F, Walitt B, Lindsay J.

Am J Cardiol. 2015 Jan 15;115(2):268-75. doi: 10.1016/j.amjcard.2014.10.035. Epub 2014 Oct 31. Review.

PMID:
25465939
22.

Modelling Long-Term Changes In Opioid Induced Constipation (OIC).

Altincatal A, Lawson R, King F, Marsh K.

Value Health. 2014 Nov;17(7):A565. doi: 10.1016/j.jval.2014.08.1877. Epub 2014 Oct 26. No abstract available.

23.

Self Reported Health Care Resource Use and Indirect Economic Burden of Opioid Induced Constipation (Oic).

Alemayehu B, Coyne KS, King F.

Value Health. 2014 Nov;17(7):A541. doi: 10.1016/j.jval.2014.08.1741. Epub 2014 Oct 26. No abstract available.

24.

How Does Non-Malignant Opioid Induced Constipation (Oic) Impact Health State Utility?

Lawson R, Marsh K, Altincatal A, King F.

Value Health. 2014 Nov;17(7):A369. doi: 10.1016/j.jval.2014.08.833. Epub 2014 Oct 26. No abstract available.

25.

Direct Health Care Costs Associated With Opioid-Induced Constipation.

Lawson R, Haycock L, Laxman K, King F, Gardner K.

Value Health. 2014 Nov;17(7):A364-5. doi: 10.1016/j.jval.2014.08.810. Epub 2014 Oct 26. No abstract available.

26.

A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo.

Lewis ND, Patnaude LA, Pelletier J, Souza DJ, Lukas SM, King FJ, Hill JD, Stefanopoulos DE, Ryan K, Desai S, Skow D, Kauschke SG, Broermann A, Kuzmich D, Harcken C, Hickey ER, Modis LK.

PLoS One. 2014 Jun 26;9(6):e100883. doi: 10.1371/journal.pone.0100883. eCollection 2014.

27.

Tracked ultrasonography snapshots enhance needle guidance for percutaneous renal access: a pilot study.

Ungi T, Beiko D, Fuoco M, King F, Holden MS, Fichtinger G, Siemens DR.

J Endourol. 2014 Sep;28(9):1040-5. doi: 10.1089/end.2014.0011. Epub 2014 May 28.

PMID:
24745550
28.

Cyclisation reactions of N-cinnamoyl-9-aminoanthracenes.

King FD, Aliev A, Caddick S, Tocher D.

Org Biomol Chem. 2014 May 28;12(20):3211-21. doi: 10.1039/c4ob00411f. Epub 2014 Apr 11.

PMID:
24722646
29.

Biomechanical comparison of reverse total shoulder arthroplasty systems in soft tissue-constrained shoulders.

Henninger HB, King FK, Tashjian RZ, Burks RT.

J Shoulder Elbow Surg. 2014 May;23(5):e108-17. doi: 10.1016/j.jse.2013.08.008. Epub 2013 Nov 23.

PMID:
24280351
30.

Spinal curvature measurement by tracked ultrasound snapshots.

Ungi T, King F, Kempston M, Keri Z, Lasso A, Mousavi P, Rudan J, Borschneck DP, Fichtinger G.

Ultrasound Med Biol. 2014 Feb;40(2):447-54. doi: 10.1016/j.ultrasmedbio.2013.09.021. Epub 2013 Nov 19.

PMID:
24268452
31.

The triflic acid-mediated cyclization reactions of N-cinnamoyl-1-naphthylamines.

King FD, Aliev AE, Caddick S, Tocher DA.

J Org Chem. 2013 Nov 1;78(21):10938-46. doi: 10.1021/jo4018827. Epub 2013 Oct 24.

PMID:
24093644
32.

Glucocorticoid receptor ligands modulate Cardiovirus encephalomyocarditis virus internal ribosome entry site activity.

Didiot MC, Agarinis C, Varin T, Wu H, Nelson T, Selinger DW, King F, Schuffenhauer A, Parker CN.

Assay Drug Dev Technol. 2013 Jul;11(6):355-66. doi: 10.1089/adt.2013.523. Epub 2013 Aug 1.

PMID:
23906347
33.

The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.

Dording C, Cassiello C, King F 4th, Pencina M, Fava M, Mischoulon D.

Int Clin Psychopharmacol. 2013 Sep;28(5):238-44. doi: 10.1097/YIC.0b013e32836220df.

PMID:
23764521
34.

Enhancing the mental health promotion component of a health and personal development programme in Irish schools.

Fitzpatrick C, Conlon A, Cleary D, Power M, King F, Guerin S.

Adv Sch Ment Health Promot. 2013 Apr;6(2):122-138.

35.

Identification of risks associated with the prescribing and dispensing of oral anticancer medicines in Ireland.

Hammond L, Marsden E, O'Hanlon N, King F, Henman MC, Keane C.

Int J Clin Pharm. 2012 Dec;34(6):893-901. doi: 10.1007/s11096-012-9688-1. Epub 2012 Sep 9.

PMID:
22961608
36.

Chemical and biological properties of frequent screening hits.

Che J, King FJ, Zhou B, Zhou Y.

J Chem Inf Model. 2012 Apr 23;52(4):913-26. doi: 10.1021/ci300005y. Epub 2012 Apr 12.

PMID:
22435989
37.

The acid-mediated ring opening reactions of α-aryl-lactams.

King FD, Caddick S.

Org Biomol Chem. 2012 Apr 28;10(16):3244-52. doi: 10.1039/c2ob00012a. Epub 2012 Mar 12.

PMID:
22406974
38.

Structures in solutions from joint experimental-computational analysis: applications to cyclic molecules and studies of noncovalent interactions.

Aliev AE, Mia ZA, Khaneja HS, King FD.

J Phys Chem A. 2012 Jan 26;116(3):1093-109. doi: 10.1021/jp211083f. Epub 2012 Jan 18.

PMID:
22204632
39.

Cost impact of trastuzumab prescribing in the treatment of advanced Her2 positive gastric cancer in Ireland.

Collins IM, King F, O'Byrne K.

Ir J Med Sci. 2012 Sep;181(3):451-2. doi: 10.1007/s11845-011-0772-7. Epub 2011 Oct 20. No abstract available.

PMID:
22012551
40.

Multiplexed reporter gene assays: monitoring the cell viability and the compound kinetics on luciferase activity.

Didiot MC, Serafini S, Pfeifer MJ, King FJ, Parker CN.

J Biomol Screen. 2011 Aug;16(7):786-93. doi: 10.1177/1087057111407768. Epub 2011 Jun 21.

PMID:
21693766
41.

Seeing the light: luminescent reporter gene assays.

Miraglia LJ, King FJ, Damoiseaux R.

Comb Chem High Throughput Screen. 2011 Sep;14(8):648-57. Review.

PMID:
21564017
42.

Triflic acid-mediated phenylation of N-acylaminoalkyl diethylacetals and N-acyl-2-phenyl cyclic amides.

King FD, Caddick S.

Org Biomol Chem. 2011 Jun 7;9(11):4361-6. doi: 10.1039/c0ob01149e. Epub 2011 Apr 20.

PMID:
21505685
43.

Compact wave functions for the beryllium isoelectronic series, Li- to Ne6+: a standard Hylleraas approach.

King FW, Quicker D, Langer J.

J Chem Phys. 2011 Mar 28;134(12):124114. doi: 10.1063/1.3569565.

PMID:
21456652
44.

The prevalence of urogenital micro-organisms detected by a multiplex PCR-reverse line blot assay in women attending three sexual health clinics in Sydney, Australia.

McKechnie ML, Hillman RJ, Jones R, Lowe PC, Couldwell DL, Davies SC, King F, Kong F, Gilbert GL.

J Med Microbiol. 2011 Jul;60(Pt 7):1010-6. doi: 10.1099/jmm.0.029108-0. Epub 2011 Mar 17.

PMID:
21415210
45.

Mass-spectrometric characterization of cisplatin binding sites on native and denatured ubiquitin.

Zhao T, King FL.

J Biol Inorg Chem. 2011 Apr;16(4):633-9. doi: 10.1007/s00775-011-0767-x. Epub 2011 Mar 2.

PMID:
21365334
46.

An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors.

Ritner C, Wong SS, King FW, Mihardja SS, Liszewski W, Erle DJ, Lee RJ, Bernstein HS.

PLoS One. 2011 Jan 4;6(1):e16004. doi: 10.1371/journal.pone.0016004.

47.

A novel synthesis of (di)-benzazocinones via an endocyclic N-acyliminium ion cyclisation.

King FD, Aliev AE, Caddick S, Tocher DA.

Org Biomol Chem. 2011 Mar 7;9(5):1547-54. doi: 10.1039/c0ob00559b. Epub 2011 Jan 13.

PMID:
21234463
48.

Introduction of a simple Web-based calculator for drug dosing.

Collins I, Doyle P, King F, O'Donnell D.

Ir Med J. 2010 Sep;103(8):251-2. No abstract available.

PMID:
21049590
49.

High-throughput tracking of pluripotent human embryonic stem cells with dual fluorescence resonance energy transfer molecular beacons.

King FW, Liszewski W, Ritner C, Bernstein HS.

Stem Cells Dev. 2011 Mar;20(3):475-84. doi: 10.1089/scd.2010.0219. Epub 2010 Sep 14.

50.

Improved expression of secreted and membrane-targeted proteins in insect cells.

Hitchman RB, Possee RD, Siaterli E, Richards KS, Clayton AJ, Bird LE, Owens RJ, Carpentier DC, King FL, Danquah JO, Spink KG, King LA.

Biotechnol Appl Biochem. 2010 Jun 21;56(3):85-93. doi: 10.1042/BA20090130.

PMID:
20441568

Supplemental Content

Support Center